Abdominal Obesity: Clinical Trials

1 trial for Abdominal Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Abdominal Obesity: new trials by email Literature Review of Abdominal Obesity trials Research Report on Abdominal Obesity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Adiposity Related hypErTension (TARGET)
Aliskiren, Moxonidine, Hydrochlorothiazide - Hypertension, Abdominal Obesity
Phase 4CompletedUMC Utrecht322010-08-012012-02-24

Narrower conditions

Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Obesity, Abdominal (1)

Broader conditions

Body Weight (1)  ·  Cardiovascular Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Insulin Resistance (1)  ·  Metabolic Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Hydrochlorothiazide (1)  ·  aliskiren (1)  ·  moxonidine (1)

Sponsors

UMC Utrecht (1)

Countries

Netherlands (1)

Top investigators

W. Spiering, MD PhD (1)

Results publications

PMID 29085669